Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome

Por Ritchie, Ellen K
Publicado em 2012

Are low-intensity induction strategies better for older patients with acute myeloid leukemia?

Por Roboz, Gail J., Wissa, Usama, Ritchie, Ellen K., Gergis, Usama, Mayer, Sebastian, Scandura, Joseph M., Christos, Paul J., Feldman, Eric J.
Publicado em 2012

Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia

Por Ritchie, Ellen K., Feldman, Eric J., Christos, Paul J., Rohan, Sarah D., Lagassa, Catherine B., Ippoliti, Cindy, Scandura, Joseph M., Carlson, Karen, Roboz, Gail J.
Publicado em 2013

Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemias or high-risk myelodysplastic syndromes

Por Roboz, Gail J., Khoury, H. Jean, Jabbour, Elias, Session, Wilena, Ritchie, Ellen K., Miao, Harry, Faderl, Stefan, Zheng, Wei, Feldman, Eric J., Arellano, Martha, Morrison, J. Gilmour, Ravandi, Farhad
Publicado no Leuk Lymphoma (2015)

Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations

Por Mencia-Trinchant, Nuria, Hu, Yang, Alas, Maria Antonina, Ali, Fatima, Wouters, Bas J., Lee, Sangmin, Ritchie, Ellen K., Desai, Pinkal, Guzman, Monica L., Roboz, Gail J., Hassane, Duane C.
Publicado no J Mol Diagn (2017)

First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leuk...

Por Feldman, Eric J., Lancet, Jeffrey E., Kolitz, Jonathan E., Ritchie, Ellen K., Roboz, Gail J., List, Alan F., Allen, Steven L., Asatiani, Ekatherine, Mayer, Lawrence D., Swenson, Christine, Louie, Arthur C.
Publicado no J Clin Oncol (2011)

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML

Por Scandura, Joseph M., Roboz, Gail J., Moh, Michelle, Morawa, Ewelina, Brenet, Fabienne, Bose, J. Robi, Villegas, Luis, Gergis, Usama S., Mayer, Sebastian A., Ippoliti, Cindy M., Curcio, Tania J., Ritchie, Ellen K., Feldman, Eric J.
Publicado em 2011

Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F

Por Stein, Brady L., Oh, Stephen T., Berenzon, Dmitriy, Hobbs, Gabriela S., Kremyanskaya, Marina, Rampal, Raajit K., Abboud, Camille N., Adler, Kenneth, Heaney, Mark L., Jabbour, Elias J., Komrokji, Rami S., Moliterno, Alison R., Ritchie, Ellen K., Rice, Lawrence, Mascarenhas, John, Hoffman, Ronald
Publicado no J Clin Oncol (2015)

Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy

Por Jacobs, Samantha E., Lamson, Daryl M., Soave, Rosemary, Guzman, Brigitte Huertas, Shore, Tsiporah B., Ritchie, Ellen K., Zappetti, Dana, Satlin, Michael J., Leonard, John P., Besien, Koen van, Schuetz, Audrey N., Jenkins, Stephen G., George, Kirsten St., Walsh, Thomas J.
Publicado no J Clin Virol (2015)

Phase I dose escalation study of lestaurtinib in patients with myelofibrosis

Por Hexner, Elizabeth O, Mascarenhas J, John, Prchal, Josef, Roboz, Gail J, Baer, Maria R, Ritchie, Ellen K, Leibowitz, David, Demakos, Erin P, Miller, Crystal, Siuty, James, Kleczko, Jill, Price, Leah, Jeschke, Grace, Weinberg, Rona, Basu T, Titiksha, Pahl, Heike L, Orazi, Attilio, Najfeld, Vesna, Marchioli, Roberto, Goldberg, Judith D, Silverman, Lewis R, Hoffman, Ronald
Publicado no Leuk Lymphoma (2015)

Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia

Por Karp, Judith E., Vener, Tatiana I., Raponi, Mitch, Ritchie, Ellen K., Smith, B. Douglas, Gore, Steven D., Morris, Lawrence E., Feldman, Eric J., Greer, Jacqueline M., Malek, Sami, Carraway, Hetty E., Ironside, Valerie, Galkin, Steven, Levis, Mark J., McDevitt, Michael A., Roboz, Gail R., Gocke, Christopher D., Derecho, Carlo, Palma, John, Wang, Yixin, Kaufmann, Scott H., Wright, John J., Garret-Mayer, Elizabeth
Publicado em 2012

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, mult...

Por Ravandi, Farhad, Ritchie, Ellen K., Sayar, Hamid, Lancet, Jeffrey E., Craig, Michael D., Vey, Norbert, Strickland, Stephen A., Schiller, Gary J., Jabbour, Elias, Erba, Harry P., Pigneux, Arnaud, Horst, Heinz-August, Recher, Christian, Klimek, Virginia M., Cortes, Jorge, Roboz, Gail J., Odenike, Olatoyosi, Thomas, Xavier, Havelange, Violaine, Maertens, Johan, Derigs, Hans-Günter, Heuser, Michael, Damon, Lloyd, Powell, Bayard L., Gaidano, Gianluca, Carella, Angelo-Michele, Wei, Andrew, Hogge, Donna, Craig, Adam R., Fox, Judith A., Ward, Renee, Smith, Jennifer A., Acton, Gary, Mehta, Cyrus, Stuart, Robert K., Kantarjian, Hagop M.
Publicado no Lancet Oncol (2015)